BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Hippocampus
,
Human chorionic gonadotropin
,
Valproic acid
,
rs2476601
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
erbb pathways
Summary
General Info
Curated Studies
Most Correlated Studies
Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
PTEN-deficiency in luminal MMTV-ErbB-2 mouse mammary tumor model
Chicken embryo fibroblast DF-1 cells overexpressing Mareks disease oncoprotein, Meq
Breast adenocarcinoma MDA-MB-361 cells depleted of DCD
Embryonic dorsal root ganglion gene expression in Erk1 and Erk2 conditional knockout mice
Explore Curated Studies Results
Literature
Most Relevant Literature
H3K27ac-activated EGFR-AS1 promotes cell growth in cervical cancer through ACTN4-mediated WNT pathwa…
EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?
RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways.
The story of EGFR: from signaling pathways to a potent anticancer target.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV,…
Iressa 2nd Line Phase III Study in Japan
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck
Phase I/II Trial of Antagonism of HER in GI Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ